123 related articles for article (PubMed ID: 12515704)
1. Early in vivo detection of metabolic response: a pilot study of 1H MR spectroscopy in extracranial lymphoma and germ cell tumours.
Schwarz AJ; Maisey NR; Collins DJ; Cunningham D; Huddart R; Leach MO
Br J Radiol; 2002 Dec; 75(900):959-66. PubMed ID: 12515704
[TBL] [Abstract][Full Text] [Related]
2. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience.
Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK
J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465
[TBL] [Abstract][Full Text] [Related]
3. Improved diagnostic accuracy in differentiating malignant and benign lesions using single-voxel proton MRS of the breast at 3 T MRI.
Suppiah S; Rahmat K; Mohd-Shah MN; Azlan CA; Tan LK; Aziz YF; Vijayananthan A; Wui AL; Yip CH
Clin Radiol; 2013 Sep; 68(9):e502-10. PubMed ID: 23706826
[TBL] [Abstract][Full Text] [Related]
4. Increased choline levels coincide with enhanced proliferative activity of human neuroepithelial brain tumors.
Herminghaus S; Pilatus U; Möller-Hartmann W; Raab P; Lanfermann H; Schlote W; Zanella FE
NMR Biomed; 2002 Oct; 15(6):385-92. PubMed ID: 12357552
[TBL] [Abstract][Full Text] [Related]
5. Prediction of pathologic response to neoadjuvant chemotherapy in patients with breast cancer using diffusion-weighted imaging and MRS.
Shin HJ; Baek HM; Ahn JH; Baek S; Kim H; Cha JH; Kim HH
NMR Biomed; 2012 Dec; 25(12):1349-59. PubMed ID: 22566277
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo (1)H MR spectroscopy--a pilot study at 4 T.
Meisamy S; Bolan PJ; Baker EH; Bliss RL; Gulbahce E; Everson LI; Nelson MT; Emory TH; Tuttle TM; Yee D; Garwood M
Radiology; 2004 Nov; 233(2):424-31. PubMed ID: 15516615
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer.
Jagannathan NR; Kumar M; Seenu V; Coshic O; Dwivedi SN; Julka PK; Srivastava A; Rath GK
Br J Cancer; 2001 Apr; 84(8):1016-22. PubMed ID: 11308247
[TBL] [Abstract][Full Text] [Related]
8. In vivo proton MR spectroscopy of the breast using the total choline peak integral as a marker of malignancy.
Sardanelli F; Fausto A; Di Leo G; de Nijs R; Vorbuchner M; Podo F
AJR Am J Roentgenol; 2009 Jun; 192(6):1608-17. PubMed ID: 19457825
[TBL] [Abstract][Full Text] [Related]
9. In vivo MRS of locally advanced breast cancer: characteristics related to negative or positive choline detection and early monitoring of treatment response.
Bathen TF; Heldahl MG; Sitter B; Vettukattil R; Bofin A; Lundgren S; Gribbestad IS
MAGMA; 2011 Dec; 24(6):347-57. PubMed ID: 21909791
[TBL] [Abstract][Full Text] [Related]
10. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
[TBL] [Abstract][Full Text] [Related]
11. In vivo MR spectroscopy predicts high tumor grade in endometrial cancer.
Ytre-Hauge S; Esmaeili M; Sjøbakk TE; Grüner R; Woie K; Werner HM; Krakstad C; Bjørge L; Salvesen ØO; Stefansson IM; Trovik J; Bathen TF; Haldorsen IS
Acta Radiol; 2018 Apr; 59(4):497-505. PubMed ID: 28927296
[TBL] [Abstract][Full Text] [Related]
12. Predicting long-term survival and treatment response in breast cancer patients receiving neoadjuvant chemotherapy by MR metabolic profiling.
Cao MD; Sitter B; Bathen TF; Bofin A; Lønning PE; Lundgren S; Gribbestad IS
NMR Biomed; 2012 Feb; 25(2):369-78. PubMed ID: 21823183
[TBL] [Abstract][Full Text] [Related]
13. Cutoff value of choline concentration reliably reveals high-grade brain tumors among other contrast-enhancing brain lesions.
Porto L; Hattingen E; Stuecher A; Herminghaus S; Lanfermann H; Ulrich Pilatus UP
J Neurol Surg A Cent Eur Neurosurg; 2012 May; 73(3):147-52. PubMed ID: 22190143
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of in vivo ovarian cancer models by quantitative 1H magnetic resonance spectroscopy and diffusion-weighted imaging.
Canese R; Pisanu ME; Mezzanzanica D; Ricci A; Paris L; Bagnoli M; Valeri B; Spada M; Venditti M; Cesolini A; Rodomonte A; Giannini M; Canevari S; Podo F; Iorio E
NMR Biomed; 2012 Apr; 25(4):632-42. PubMed ID: 22020805
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of MR spectroscopy for characterizing malignant breast lesions using a clinical 3-T scanner.
Baek HM; Lee YJ
Breast Cancer; 2015 Sep; 22(5):510-9. PubMed ID: 24390858
[TBL] [Abstract][Full Text] [Related]
16. [1H-MR Spectroscopy of brain tumors in the course of radiation therapy: Use of fast spectroscopic imaging and single-voxel spectroscopy for diagnosing recurrence].
Träber F; Block W; Flacke S; Lamerichs R; Schüller H; Urbach H; Keller E; Schild HH
Rofo; 2002 Jan; 174(1):33-42. PubMed ID: 11793282
[TBL] [Abstract][Full Text] [Related]
17. Study of single voxel 1H MR spectroscopy of bone tumors: differentiation of benign from malignant tumors.
Zhang J; Cheng K; Ding Y; Liang W; Ding Y; Vanel D; Cheng X
Eur J Radiol; 2013 Dec; 82(12):2124-8. PubMed ID: 22169357
[TBL] [Abstract][Full Text] [Related]
18. MR spectroscopy differentiation between high and low grade astrocytomas: a comparison between paediatric and adult tumours.
Porto L; Kieslich M; Franz K; Lehrnbecher T; Zanella F; Pilatus U; Hattingen E
Eur J Paediatr Neurol; 2011 May; 15(3):214-21. PubMed ID: 21145271
[TBL] [Abstract][Full Text] [Related]
19. Levels of choline-containing compounds in normal liver and liver metastases of colorectal cancer as recorded by
Ter Voert EEGW; Heijmen L; van Asten JJA; Wright AJ; Nagtegaal ID; Punt CJA; de Wilt JHW; van Laarhoven HWM; Heerschap A
NMR Biomed; 2019 Jan; 32(1):e4035. PubMed ID: 30457686
[TBL] [Abstract][Full Text] [Related]
20. In vivo proton MR spectroscopy reveals altered metabolite content in malignant prostate tissue.
Heerschap A; Jager GJ; van der Graaf M; Barentsz JO; de la Rosette JJ; Oosterhof GO; Ruijter ET; Ruijs SH
Anticancer Res; 1997; 17(3A):1455-60. PubMed ID: 9179183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]